Author

David S. Garvey

University of California San Diego

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Approach:deep learning· 1 Approach:graph neural network· 1 Research Focus:perturbation response prediction· 1 Research Focus:sequence-to-function modeling· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam Presser· 1 shared Cameron Fraser· 1 shared Daniel J. HadersiD· 1 shared Davey Mitchell SmithiD· 1 shared Jarvier N. MohammediD· 1 shared Jerry E. ChipukiD· 1 shared Jesse D. GellesiD· 1 shared Kristopher A. SarosiekiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Adam Presser

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A peptide-based screen for cell death inhibitors identifies the cytoprotective compound CDL36

Zintis Inde, Sebastian Keppler, Jesse D. Gelles, Cameron Fraser, Adam Presser, Jarvier N. Mohammed, May Jung, David S. Garvey, Tudor Moldoveanu, Jerry E. Chipuk, Kristopher A. Sarosiek

The paper identifies CDL36, a compound that inhibits cell death by preventing mitochondrial outer membrane permeabilization, with potent cytoprotection against doxorubicin-induced toxicity.

bioRxiv · Jul 10, 2026 · PreprintMolecular Biology

GALILEO Generatively Expands Chemical Space and Achieves One-Shot Identification of a Library of Novel, Specific, Next Generation Broad-Spectrum Antiviral Compounds at High Hit Rates

Tyler J. Umansky, Virgil L. Woods, Sean M. Russell, David S. Garvey, Davey Mitchell Smith, Daniel J. Haders

This study uses GALILEO and ChemPrint to generate novel antiviral compounds targeting the conserved Thumb-1 site, achieving 100% hit rate in vitro against HCV and Coronavirus 229E.

bioRxiv · Jan 17, 2025 · PreprintBioinformatics